BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23415921)

  • 1. In utero hematopoietic cell transplantation--recent progress and the potential for clinical application.
    Vrecenak JD; Flake AW
    Cytotherapy; 2013 May; 15(5):525-35. PubMed ID: 23415921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In utero hematopoietic stem cell transplantation: progress toward clinical application.
    Merianos D; Heaton T; Flake AW
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):729-40. PubMed ID: 18541191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In utero hematopoietic cell transplantation for the treatment of congenital anomalies.
    Nijagal A; Flake AW; MacKenzie TC
    Clin Perinatol; 2012 Jun; 39(2):301-10. PubMed ID: 22682381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero stem cell transplantation.
    Flake AW
    Best Pract Res Clin Obstet Gynaecol; 2004 Dec; 18(6):941-58. PubMed ID: 15582548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
    Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
    Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple Approach to Increase Donor Hematopoietic Stem Cell Dose and Improve Engraftment in the Murine Model of Allogeneic In Utero Hematopoietic Cell Transplantation.
    Vrecenak JD; Partridge EA; Pearson EG; Flake AW
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):e21-e24. PubMed ID: 31493540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell and genetic therapies for the fetus.
    Roybal JL; Santore MT; Flake AW
    Semin Fetal Neonatal Med; 2010 Feb; 15(1):46-51. PubMed ID: 19540822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intrauterine transplantation of hematopoietic stem cells for therapy of genetic diseases].
    Surbek DV; Hohlfeld P; Gratwohl A; Holzgreve W
    Z Geburtshilfe Neonatol; 1997; 201(5):158-70. PubMed ID: 9440955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current progress in chimerism and donor-specific tolerance.
    Jankowski RA; Ildstad ST
    Transplant Proc; 1996 Aug; 28(4):2071-4. PubMed ID: 8769159
    [No Abstract]   [Full Text] [Related]  

  • 10. Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice.
    Merianos DJ; Tiblad E; Santore MT; Todorow CA; Laje P; Endo M; Zoltick PW; Flake AW
    J Clin Invest; 2009 Sep; 119(9):2590-600. PubMed ID: 19652363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.
    Peranteau WH; Hayashi S; Abdulmalik O; Chen Q; Merchant A; Asakura T; Flake AW
    Blood; 2015 Sep; 126(10):1245-54. PubMed ID: 26124498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of CD 34(+) mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates.
    Shields LE; Gaur L; Delio P; Gough M; Potter J; Sieverkropp A; Andrews RG
    J Med Primatol; 2005 Aug; 34(4):201-8. PubMed ID: 16053498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonmyeloablative allogeneic hematopoietic stem cell transplantation: minitransplantation].
    Machaczka M; Rucińska M; Skotnicki AB
    Przegl Lek; 1999; 56(10):633-7. PubMed ID: 10695376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem-cell therapies for blood diseases.
    Bordignon C
    Nature; 2006 Jun; 441(7097):1100-2. PubMed ID: 16810247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation.
    Thiede C; Bornhäuser M; Ehninger G
    Acta Haematol; 2004; 112(1-2):16-23. PubMed ID: 15179000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics.
    Jimenez A; Fung HC; Christopherson KW
    Transfusion; 2011 Nov; 51 Suppl 4():125S-137S. PubMed ID: 22074623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants.
    Peranteau WH
    Front Pharmacol; 2014; 5():251. PubMed ID: 25429269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human-murine chimera model for in utero human hematopoietic stem cell transplantation.
    Leung W; Blakemore K; Jones RJ; Moser HW; Mukherjee G; Griffin CA; Rosenblum-Vos LS; Civin CI
    Biol Blood Marrow Transplant; 1999; 5(1):1-7. PubMed ID: 10232735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation in utero produces sheep-goat chimeras.
    Oppenheim SM; Muench MO; Gutiérrez-Adán A; Moyer AL; BonDurant RH; Rowe JD; Anderson GB
    Blood Cells Mol Dis; 2001; 27(1):296-308. PubMed ID: 11358392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.